Arvid Carlsson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Open study with (-)-OSU6162 in multiple sclerosis-related fatigue.
Journal: Acta neurologica Scandinavica
Published: May 02, 2018
A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome.
Journal: Acta neuropsychiatrica
Published: December 08, 2017
1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.
Journal: Acta neuropsychiatrica
Published: October 25, 2016
The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: July 06, 2015
Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study.
Journal: Acta neuropsychiatrica
Published: September 23, 2014
The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: December 23, 2013
Placebo-controlled cross-over study of the monoaminergic stabiliser (-)-OSU6162 in mental fatigue following stroke or traumatic brain injury.
Journal: Acta neuropsychiatrica
Published: October 01, 2012
The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens.
Journal: Biological psychiatry
Published: January 14, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026